
Dysbiotic oral biofilm doesn't stay in the mouth. High-risk pathogens - P. gingivalis, T. denticola, T. forsythia - drive systemic inflammation linked to cardiovascular disease, diabetes, respiratory illness, and adverse pregnancy outcomes. Knowing which bacteria are present, and at what load, changes the clinical decisions you make every appointment.
Pairing Guided Biofilm Therapy® with OralDNA® MyPerioPath® salivary diagnostics transforms routine hygiene into precision, documented care. Baseline testing guides targeted antibiotic selection and adjunctive therapy. Post-treatment retesting confirms measurable pathogen reduction - objective evidence that supports physician co-management and long-term patient outcomes. GBT's 8-step protocol - Assess, Disclose, Motivate, AIRFLOW®, PERIOFLOW®, PIEZON®, Check, and Recall + Retest - reduces chair time, minimizes patient discomfort, and eliminates guesswork. OralDNA® turns clinical decisions into defensible, documented outcomes.
Precision diagnostics. Evidence-based protocol. Better results for your patients and your practice.
GBT® Treatment Recommendations
CONTACT INFORMATION
